Next Article in Journal
Does Continuous Exposure to ZnO and TiO2 NPs Cause any Changes in Keratinocytes?
Previous Article in Journal
Important Parameters in Cytotoxicity Testing of Nanoparticles
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 78
Issue 3
10.3797/scipharm.cespt.8.LNT02
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

Development of Solid Lipid Nanoparticles for Praziquantel Delivery: Particle Size Characterization and Cell Toxicity Assessment

by
A. L. R. SOUZA
1,2,*,
T. ANDREANI
2,
S. DOKTOROVOVÁ
3,
A. M. SILVA
2,4,
E. B. SOUTO
5 and
M. P. D. GREMIÃO
1
1
Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, UNESP, Araraquara, Brazil
2
Department of Biology and Environment, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
3
Centre of Genomics and Biotechnology, IBB/CGB-UTAD, Vila-Real, Portugal
4
Centre for Research and Technology of Agro-Environmental and Biological Sciences, Vila Real, Portugal
5
Department of Pharmaceutical Technology, Faculty of Health Sciences, UFP, Porto, Portugal
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 576; https://doi.org/10.3797/scipharm.cespt.8.LNT02
Submission received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Praziquantel (PZQ) is a drug active against all species of Schistosoma and it is the drug of choice for the treatment of schistosomiasis [1]. [...]

Share and Cite

MDPI and ACS Style

SOUZA, A.L.R.; ANDREANI, T.; DOKTOROVOVÁ, S.; SILVA, A.M.; SOUTO, E.B.; GREMIÃO, M.P.D. Development of Solid Lipid Nanoparticles for Praziquantel Delivery: Particle Size Characterization and Cell Toxicity Assessment. Sci. Pharm. 2010, 78, 576. https://doi.org/10.3797/scipharm.cespt.8.LNT02

AMA Style

SOUZA ALR, ANDREANI T, DOKTOROVOVÁ S, SILVA AM, SOUTO EB, GREMIÃO MPD. Development of Solid Lipid Nanoparticles for Praziquantel Delivery: Particle Size Characterization and Cell Toxicity Assessment. Scientia Pharmaceutica. 2010; 78(3):576. https://doi.org/10.3797/scipharm.cespt.8.LNT02

Chicago/Turabian Style

SOUZA, A. L. R., T. ANDREANI, S. DOKTOROVOVÁ, A. M. SILVA, E. B. SOUTO, and M. P. D. GREMIÃO. 2010. "Development of Solid Lipid Nanoparticles for Praziquantel Delivery: Particle Size Characterization and Cell Toxicity Assessment" Scientia Pharmaceutica 78, no. 3: 576. https://doi.org/10.3797/scipharm.cespt.8.LNT02

Article Metrics

Back to TopTop